Thursday, April 18, 2024 8:38:20 AM
Natural Shrimp, Inc. Completes Successful Trial in Japan
8:30 AM ET 4/18/24 | PR Newswire
Related Quotes
12:00 AM ET 12/30/99
Symbol Last % Chg
SHMP
0.01 0.00%
Real time quote.
Natural Shrimp, Inc. Completes Successful Trial in Japan
PR Newswire
DALLAS, April 18, 2024
Patented Electrocoagulation (EC) and Hydrogas(TM) Technologies Results from Trial at Aquaculture Farm in Japan
DALLAS, April 18, 2024 /PRNewswire/ -- Natural Shrimp, Inc. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas(TM) technologies (the "Equipment").
One week after arriving in Japan, the Natural Shrimp and Hydrenesis' team, with the assistance of the Japanese team, installed and began operating the Equipment at the Japanese shrimp research facility. The trial compared a tank treated by the EC and Hydrogas(TM) with a tank treated by a traditional biofilter. Throughout the 6-month trial, the EC effectively removed the ammonia from the water. In addition, the shrimp growth rate increased during the presence of Hydrogas when compared to the shrimp growth rate in the tank treated only by the biofilter.
Natural Shrimp supported the trial by making three (3) trips to Japan during the Trial Period and continued to actively participate in the Trial by remote access to the Equipment between trips. However, after initial instruction by the NSI team, the Japanese team was able to independently operate the EC and Hydrogas equipment on their own. The Japanese team performed extensive testing of the Equipment that included, among other things, collecting data under varying conditions by testing different flow rates, ammonia levels, and amperage levels. Based on the empirical results demonstrated by the Equipment during the Trial, Natural Shrimp looks to either joint venture, License or form a business combination in Japan.
Tom Untermeyer, Natural Shrimp Chief Technology Officer said, "I very much enjoyed working with the team in Japan during the installation and operation of our Equipment in the Japanese shrimp research facility. The Japanese quickly learned how to operate the EC and Hydrogas equipment and shared with us the data that they collected during the trial. The Japanese market is uniquely set up for the NSI technology based on its current shrimp import conditions and a robust consumption of shrimp as a primary protein source. I am excited to see where this will lead us in the future with the hope of helping them and others develop successful shrimp production systems using our technologies."
About Natural Shrimp
Natural Shrimp, Incorporated is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas, and Webster City, Iowa. The Company has developed the first commercially viable system for growing shrimp in enclosed salt-water systems using patented technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Natural Shrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. For more information visit www.naturalshrimp.com.
Recent SHMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:30:31 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:56:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 10:01:21 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/08/2023 03:52:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 08:31:49 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2023 04:15:19 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:20:31 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/11/2023 08:52:47 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2023 09:04:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 09:20:28 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM